Douglas Evan Godshall - 14 Nov 2022 Form 4/A - Amendment Insider Report for Shockwave Medical, Inc.

Role
President & CEO, Director
Signature
/s/ Wade Estey, as attorney-in-fact for Douglas Godshall
Issuer symbol
N/A
Transactions as of
14 Nov 2022
Net transactions value
+$102,480
Form type
4/A - Amendment
Filing time
02 Dec 2022, 19:19:51 UTC
Date Of Original Report
16 Nov 2022
Previous filing
02 Dec 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $102,480 +30,000 +27% $3.42 142,926 14 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -30,000 -7.1% $0.000000 394,799 14 Nov 2022 Common Stock 30,000 $3.42 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022.
F2 Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments.

Remarks:

This Form 4 is being amended to correct the following in Table I and Table II, above: (i) add reference to an option exercise on November 14, 2022 of 30,000 shares ; and (ii) correct and restate the aggregate ownership of Common Stock of the Issuer held by the Reporting Person as of November 14, 2022, pursuant to the foregoing correction.